Search

everythinglearnresearchcommunity

for

Search:↓

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Two-photon microscopy helps observe hair follicle stem cell behaviors in mice.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Low color temperature light (1900 K) benefits health by promoting melatonin, protecting eyes, and aiding healing.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hormonal therapies are safe and effective for treating adult women's acne.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.